Comparative Effectiveness of Prophylactic Therapies for Necrotizing Enterocolitis in Preterm Infants: Protocol for a

Behnam Sadeghirad1,2, Ivan D Florez1,3, Yaping Chang1

  • 1Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada.

Insights

This study compares therapies to prevent necrotizing enterocolitis (NEC) in premature infants. It aims to provide evidence for optimal NEC prevention strategies, improving infant outcomes.

Area of Science:

  • Neonatal Medicine
  • Pediatric Gastroenterology
  • Evidence-Based Medicine

Background:

  • Necrotizing enterocolitis (NEC) is a severe gastrointestinal disease affecting premature infants, characterized by high morbidity and mortality.
  • Existing research on NEC prevention lacks comprehensive comparisons of available therapies, hindering evidence-based clinical decision-making.
  • Identifying effective preventive strategies is crucial for improving outcomes in vulnerable preterm and low birth weight infants.

Purpose of the Study:

  • To systematically identify and evaluate all eligible trials assessing preventive interventions for necrotizing enterocolitis (NEC) in preterm and/or low birth weight infants.
  • To compare the efficacy and safety of various NEC preventive therapies through conventional and network meta-analyses.
  • To provide a comprehensive overview of evidence for NEC prevention, informing clinical practice and future research.

Main Methods:

  • A systematic literature search will be conducted across multiple databases (MEDLINE, EMBASE, etc.) and grey literature.
  • Eligible studies will include randomized trials in preterm or low birth weight infants comparing preventive interventions to placebo or other interventions.
  • Conventional and network meta-analyses will be performed to assess outcomes including severe NEC, mortality, sepsis, and hospitalization duration, with certainty assessed using GRADE.

Main Results:

  • The study will synthesize data from eligible randomized controlled trials on NEC preventive therapies.
  • Meta-analyses will quantify the relative effects of different interventions on key clinical outcomes.
  • The certainty of evidence for direct, indirect, and network estimates will be rigorously assessed.

Conclusions:

  • This systematic review and meta-analysis will provide a robust comparison of NEC preventive therapies.
  • Findings will address current literature limitations, offering valuable insights for optimizing NEC prevention in clinical settings.
  • The study aims to contribute to improved survival and reduced long-term complications for infants at risk of NEC.

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
605
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
424
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.7K